Agenus | AGEN - Vermögenswerte





Vermögenswerte Veränderung Datum
AbbVie USD 135.12B 1.35B 2026-06
Agenus USD 172.69M 13.76M 2026-06
Amgen USD 95.64B 3.14B 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Celldex Therapeutics USD 782.35M 271.09M 2026-06
CSL USD 37.9B 1.5B 2025-12
Eli Lilly USD 142.28B 25.71B 2026-06
Gilead Sciences USD 49.36B 6.92B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Glaxosmithkline GBP 62.87B 19.47B 2026-03
Incyte USD 7.87B 533.53M 2026-06
Intrexon USD 73.16M 77.88M 2024-06
J&J USD 201.06B 167M 2026-06
Jiangsu Hengrui CNY 70.77B 520.74M 2026-06
Karyopharm Therapeutics USD 131.42M 23M 2026-03
MacroGenics USD 345.41M 127.54M 2026-06
Merck EUR 52.69B 383M 2026-06
Merck USD 129.8B 1.12B 2026-06
Northwest Biotherapeutics USD 80.05M 49.44M 2026-03
Novartis USD 122.03B 3.5B 2026-06
Novavax USD 955.58M 87.59M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Veracyte USD 1.49B 49.97M 2026-06